206 related articles for article (PubMed ID: 21922751)
1. [Vaccine adjuvant].
Aoshi T; Ishii KJ
Nihon Rinsho; 2011 Sep; 69(9):1547-53. PubMed ID: 21922751
[TBL] [Abstract][Full Text] [Related]
2. From tolerance to autoimmunity: is there a risk in early life vaccination?
Goriely S; Goldman M
J Comp Pathol; 2007 Jul; 137 Suppl 1():S57-61. PubMed ID: 17548092
[TBL] [Abstract][Full Text] [Related]
3. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
[TBL] [Abstract][Full Text] [Related]
4. Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions.
Lang R; Schoenen H; Desel C
Immunobiology; 2011 Nov; 216(11):1184-91. PubMed ID: 21742403
[TBL] [Abstract][Full Text] [Related]
5. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
6. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
[TBL] [Abstract][Full Text] [Related]
7. Adjuvants and autoimmunity.
Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1217-25. PubMed ID: 19880572
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity and vaccine.
Seya T
Vaccine; 2010 Nov; 28(50):8041-2. PubMed ID: 20849873
[TBL] [Abstract][Full Text] [Related]
9. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
Jasani B; Navabi H; Adams M
Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of cytokines.
Tovey MG; Lallemand C
Methods Mol Biol; 2010; 626():287-309. PubMed ID: 20099135
[TBL] [Abstract][Full Text] [Related]
11. Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines.
Qin H; Cha SC; Neelapu SS; Liu C; Wang YH; Wei J; Qin XF; Liu YJ; Kwak LW
Vaccine; 2010 Nov; 28(50):7970-8. PubMed ID: 20937320
[TBL] [Abstract][Full Text] [Related]
12. Novel adjuvants for B cell immune responses.
Loré K; Karlsson Hedestam GB
Curr Opin HIV AIDS; 2009 Sep; 4(5):441-6. PubMed ID: 20048709
[TBL] [Abstract][Full Text] [Related]
13. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
14. Immunity in response to particulate antigen-delivery systems.
Storni T; Kündig TM; Senti G; Johansen P
Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
[TBL] [Abstract][Full Text] [Related]
15. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity.
Kindrachuk J; Jenssen H; Elliott M; Townsend R; Nijnik A; Lee SF; Gerdts V; Babiuk LA; Halperin SA; Hancock RE
Vaccine; 2009 Jul; 27(34):4662-71. PubMed ID: 19539585
[TBL] [Abstract][Full Text] [Related]
16. Innate and adaptive immune pathways to tolerance.
Thornton CA; Morgan G
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
[TBL] [Abstract][Full Text] [Related]
17. Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity.
Alter G; Sekaly RP
Vaccine; 2015 Jun; 33 Suppl 2():B55-9. PubMed ID: 26022570
[TBL] [Abstract][Full Text] [Related]
18. Qualitative evaluation of adjuvant activities and its application to Th2/17 diseases.
Matsushita S; Takagi R; Hashimoto K; Higashi T
Int Arch Allergy Immunol; 2011; 155 Suppl 1():2-5. PubMed ID: 21646788
[TBL] [Abstract][Full Text] [Related]
19. Biomaterials as vaccine adjuvants.
Jones KS
Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
[TBL] [Abstract][Full Text] [Related]
20. Induction and direction of immune responses by vaccine adjuvants.
Schijns VE
Crit Rev Immunol; 2001; 21(1-3):75-85. PubMed ID: 11642615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
